MedTrace Logo

Angel® Catheter Post Market Registry

NCT02917135 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2016-12-13

No results posted yet for this study

Summary

This is a post-market, observational, retrospective multi-center Registry designed to gather information on the performance of the Angel® Catheter in general clinical practice.

Conditions

  • Pulmonary Embolism
  • Medical Device Complication
  • Deep Vein Thrombosis
  • Catheter Thrombosis
  • Catheter-related Bloodstream Infection (CRBSI) Nos

Interventions

DEVICE

Angel® Catheter

The Angel® Catheter is a retrievable inferior vena cava (IVC) filter attached to a multi-lumen central venous access (CVC) catheter. The device is designed to be placed at the bedside in the inferior vena cava, via the femoral vein, for the prevention of pulmonary embolism (PE) and for access to the central venous system. The Angel® Catheter is intended for short-term (less than 30 days) vascular access via the femoral vein.

Sponsors & Collaborators

  • BiO2 Medical

    lead INDUSTRY

Principal Investigators

  • Nicholas Bunker, MD · Royal London Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917135 on ClinicalTrials.gov